Search results
Krishna Pada Bhabak. Associate Professor. +91 361 258 3476 (O) kbhabak @ iitg ⋅ ac ⋅ in. Research Interest: Organic and Bio-organic Chemistry / Fluorogenic Drug Delivery / Synthesis and Bio-activities of Organochalcogen (S, Se) Compounds. Personal Website | Vidwan Profile. Department/Centre/School. Chemistry Centre for the Environment.
Dr. Krishna Pada Bhabak. Associate Professor. Ph.D. (IISc, Bangalore) Research Area: Organic and Bio-organic Chemistry / Fluorogenic Drug Delivery / Synthesis and Bio-activities of Organochalcogen (S, Se) Compounds. Group Website
Dr. Krishna Pada Bhabak. Indian Institute of Technology Guwahati, India. Verified email at iitg.ac.in - Homepage. Small-molecule Antioxidants Anti-cancer Compounds Fluorogenic drug delivery Sustained donors of Hydrogen sulfide. Articles 1–20.
Dr. Krishna Pada Bhabak. Associate Professor. Department of Chemistry, Room No: CHF 007. Indian Institute of Technology Guwahati. Guwahati-781039, Assam, India. Ph No: +91-361-258-3476 (office) 4344 (Lab) Fax No: +91-361258-2349. Email: kbhabak@iitg.ac.in; kbhabak@gmail.com. Education.
Dr Krishna Pada Bhabak; Assistant Professor; Indian Institute of Technology Guwahati
Krishna BHABAK, Professor (Associate) | Cited by 1,558 | of Indian Institute of Technology Guwahati, Guwahati (IIT Guwahati) | Read 46 publications | Contact Krishna BHABAK
Nikita Pal. C/O: Dr. Krishna Pada Bhabak. (Bioorganic Chemistry Research Laboratory) About Me. E-mail: n.pal@iitg.ac.in. The sequential interactions in various states and phases are the...
Bhabak, K. P.; Mugesh, G. "Synthesis and Structure-Activity Correlation Studies of Secondary- and Tertiary-Amine-Based Glutathione Peroxidase Mimics" Chem. Eur. J. 2009 , 15(38) , 9846-9854.> Home
View Krishna Pada Bhabak’s profile on LinkedIn, a professional community of 1 billion members.
- iit guwahati
Bioorganic Chemistry Research Laboratory. Research interests in our group include the design and synthesis of organic compounds or fluorescently labeled compounds or the turn-on fluorogenic drug delivery systems/prodrugs for the treatment strategies of various disease states such as cancer or inflammatory diseases.